Federated Hermes’s HOOKIPA Pharma HOOK Stock Holding History

Federated Hermes’s Portfolio HOOK Stock Details HOOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-71	Closed	-$436	–	2104
2023 Q3	$436	Hold	71	–	–	﹤0.01%	2047
2023 Q2	$623	Sell	71 -135	-66%	-$1.5K	﹤0.01%	2045
2023 Q1	$1.52K	Sell	206 -64	-24%	-$573	﹤0.01%	2019
2022 Q4	$2.19K	Sell	270 -68	-20%	-$737	﹤0.01%	1997
2022 Q3	$5K	Buy	338 +83	+33%	+$1.27K	﹤0.01%	1889
2022 Q2	$4K	Sell	255 -88	-26%	-$1.46K	﹤0.01%	1909
2022 Q1	$8K	Sell	343 -19,193	-98%	-$344K	﹤0.01%	1909
2021 Q4	$455K	Buy	19,536 +1,859	+11%	+$74.7K	﹤0.01%	1503
2021 Q3	$1.04M	Sell	17,677 -7,221	-29%	-$524K	﹤0.01%	1266
2021 Q2	$2.28M	Buy	24,898 +21,802	+704%	+$2.91M	﹤0.01%	1052
2021 Q1	$416K	Buy	+3,096	New	+$374K	﹤0.01%	1597
2020 Q2	–	Sell	-37	Closed	-$3K	–	2288
2020 Q1	$3K	Buy	+37	New	+$4.05K	﹤0.01%	1985

Other funds holding HOOK

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Federated Hermes's HOOK Position: Q4 2023 in Review

Federated Hermes sold out of HOOKIPA Pharma (HOOK) in Q4 2023, closing a stake of 71 shares — an estimated $436 sold.

Federated Hermes first reported a position in HOOK in Q1 2020 and held it in 12 quarters. The position peaked at $2.28M in Q2 2021. 41 funds tracked by Wall St. Rank hold HOOK as of Q4 2023.

Federated Hermes reported no remaining HOOKIPA Pharma position as of Q4 2023 after selling out during the quarter.
Federated Hermes sold 71 HOOKIPA Pharma shares in Q4 2023, an estimated $436.
Federated Hermes first reported a position in HOOKIPA Pharma in Q1 2020 and held it in 12 quarters.
Federated Hermes's HOOKIPA Pharma position peaked at $2.28M in Q2 2021.
41 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q4 2023.

Based on Federated Hermes's 13F filing for Q4 2023, filed 31 Jan 2024.